AstraZeneca PLC (AZN)
70.54
+0.42
(+0.60%)
USD |
NASDAQ |
Apr 23, 10:44
AstraZeneca Total Return Level: 200.78 for April 22, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 22, 2024 | 200.78 |
April 19, 2024 | 196.29 |
April 18, 2024 | 195.74 |
April 17, 2024 | 196.23 |
April 16, 2024 | 195.47 |
April 15, 2024 | 196.80 |
April 12, 2024 | 197.38 |
April 11, 2024 | 198.86 |
April 10, 2024 | 195.03 |
April 09, 2024 | 195.89 |
April 08, 2024 | 193.85 |
April 05, 2024 | 193.14 |
April 04, 2024 | 192.82 |
April 03, 2024 | 191.30 |
April 02, 2024 | 191.85 |
April 01, 2024 | 192.56 |
March 28, 2024 | 194.00 |
March 27, 2024 | 195.46 |
March 26, 2024 | 189.93 |
March 25, 2024 | 188.58 |
March 22, 2024 | 189.73 |
March 21, 2024 | 189.53 |
March 20, 2024 | 188.21 |
March 19, 2024 | 188.58 |
March 18, 2024 | 188.56 |
Date | Value |
---|---|
March 15, 2024 | 189.87 |
March 14, 2024 | 191.96 |
March 13, 2024 | 193.51 |
March 12, 2024 | 192.99 |
March 11, 2024 | 193.77 |
March 08, 2024 | 190.42 |
March 07, 2024 | 189.53 |
March 06, 2024 | 186.90 |
March 05, 2024 | 185.58 |
March 04, 2024 | 185.52 |
March 01, 2024 | 184.98 |
February 29, 2024 | 183.72 |
February 28, 2024 | 187.12 |
February 27, 2024 | 189.93 |
February 26, 2024 | 188.78 |
February 23, 2024 | 188.50 |
February 22, 2024 | 183.63 |
February 21, 2024 | 183.56 |
February 20, 2024 | 183.42 |
February 16, 2024 | 181.25 |
February 15, 2024 | 177.22 |
February 14, 2024 | 173.89 |
February 13, 2024 | 172.11 |
February 12, 2024 | 173.18 |
February 09, 2024 | 175.58 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
94.07
Minimum
May 13 2019
212.39
Maximum
Apr 24 2023
156.50
Average
155.76
Median
Jul 23 2021
Total Return Level Benchmarks
GSK PLC | 266.13 |
Amgen Inc | 378.01 |
Sanofi SA | 100.67 |
Viking Therapeutics Inc | 63.90 |
Fusion Pharmaceuticals Inc | 21.32 |